BIOCRYST PHARMACEUTICALS INC — SC 13G/A Filings
90 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by BIOCRYST PHARMACEUTICALS INC (BCRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. BIOCRYST PHARMACEUTICALS INC has filed 90 SC 13G/A documents with the SEC since 2015. To view all SEC filings by BIOCRYST PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001144204-16-082678 | Feb 16, 2016 | — |
| SC 13G/A | — | 0000315066-16-004900 | Feb 12, 2016 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-16-000680 | Feb 11, 2016 | — |
| SC 13G/A | — | 0000215457-16-002121 | Jan 25, 2016 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-010188 | Feb 17, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-010176 | Feb 17, 2015 | — |
| SC 13G/A | — | 0000315066-15-001753 | Feb 13, 2015 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-15-000002 | Jan 12, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-14-036818 | Jun 10, 2014 | — |
| SC 13G/A | — | 0000919574-14-001383 | Feb 14, 2014 | — |
| SC 13G/A | SC 13G/A | 0001144204-14-009487 | Feb 14, 2014 | — |
| SC 13G/A | — | 0001086364-13-003723 | Jul 10, 2013 | — |
| SC 13G/A | SC 13G/A | 0001144204-13-008973 | Feb 14, 2013 | — |
| SC 13G/A | — | 0000905339-12-000003 | Jan 26, 2012 | — |
| SC 13G/A | — | 0000905339-11-000012 | Jan 10, 2011 | — |
| SC 13G/A | SCH 13G/AM. 3 (02/03/10) | 0000906344-10-000019 | Feb 3, 2010 | — |
| SC 13G/A | SCHEDULE 13G HOLDINGS REPORT AMENDMENT | 0001172661-09-001421 | Sep 30, 2009 | — |
| SC 13G/A | SC 13G-A2 (02-13-09) | 0000906344-09-000350 | Feb 13, 2009 | — |
| SC 13G/A | SC 13G-A2 (02-13-09) | 0000906344-09-000348 | Feb 13, 2009 | — |
| SC 13G/A | SC 13G-A2 (02-13-09) | 0000906344-09-000365 | Feb 13, 2009 | — |
| SC 13G/A | SC 13G-A2 (02-13-09) | 0000906344-09-000367 | Feb 13, 2009 | — |
| SC 13G/A | SC 13G-A2 (02-13-09) | 0000906344-09-000370 | Feb 13, 2009 | — |
| SC 13G/A | SC 13G-A2 (02-13-09) | 0000906344-09-000376 | Feb 13, 2009 | — |
| SC 13G/A | SCHEDULE 13G/A 02-13-08 | 0000906344-08-000152 | Feb 13, 2008 | — |
| SC 13G/A | SCHEDULE 13G/A 02-13-08 | 0000906344-08-000154 | Feb 13, 2008 | — |
| SC 13G/A | SCHEDULE 13G/A 02-13-08 | 0000906344-08-000156 | Feb 13, 2008 | — |
| SC 13G/A | SCHEDULE 13G/A 02-13-08 | 0000906344-08-000150 | Feb 13, 2008 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001193805-06-000381 | Feb 14, 2006 | — |
| SC 13G/A | — | 0000930413-06-001009 | Feb 14, 2006 | — |
| SC 13G/A | BCRX AS OF 12/31/2005 | 0000080255-06-000182 | Feb 14, 2006 | — |
| SC 13G/A | BCRX AS OF 12/31/2004 | 0000080255-05-000121 | Feb 9, 2005 | — |
| SC 13G/A | — | 0001243875-04-000011 | Feb 12, 2004 | — |
| SC 13G/A | — | 0000898432-03-001229 | Dec 11, 2003 | — |
| SC 13G/A | SC 13G/A | 0000912057-02-025789 | Jun 28, 2002 | — |
| SC 13G/A | SC 13G/A | 0000912057-02-006189 | Feb 14, 2002 | — |
| SC 13G/A | SCHEDULE 13G/A | 0000912057-01-005919 | Feb 14, 2001 | — |
| SC 13G/A | — | 0000950144-01-000660 | Jan 10, 2001 | — |
| SC 13G/A | BIOCRYST PHARMACEUTICALS, INC. / MAX COOPER | 0000950144-00-002081 | Feb 14, 2000 | — |
| SC 13G/A | — | 0000864047-97-000110 | Feb 14, 1997 | — |
| SC 13G/A | — | 0000864047-96-000005 | Feb 13, 1996 | — |